Forendo Pharma
Signal active
Organization
Contact Information
Overview
Forendo Pharma is a developer of novel drugs intended for the treatment of urological and other endocrinological diseases. The company's drugs are competent in tissue-specific hormone mechanisms for the treatment of broader gynecological conditions and Fispemifene, a novel SERM, enabling medical companies to improve the treatment of male urological conditions and giving new opportunities to unmet needs in women's and men's health.
About
Industries
Health Care, Pharmaceutical, Medical
Founded
2013
Employees
11-50
Headquarters locations
Europe
Social
N/A
Profile Resume
Forendo Pharma headquartered in Europe, operates in the Health Care, Pharmaceutical, Medical sector. The company focuses on Health Care and has secured $1.8B in funding across 60 round(s). With a team of 11-50 employees, Forendo Pharma is actively contributing to advancements in Health Care. Their latest funding round, Series A - Forendo Pharma, raised $15.2M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
5
Investors
5
Lead Investors
0
Total Funding Amount
$30.7M
Details
2
Forendo Pharma has raised a total of $30.7M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2013 | Early Stage Venture | 1.6M | ||
| 2014 | Early Stage Venture | 15.2M |
Investors
Forendo Pharma is funded by 34 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Novo Holdings | - | FUNDING ROUND - Novo Holdings | 15.2M |
| Finnvera Venture Capital | - | FUNDING ROUND - Finnvera Venture Capital | 15.2M |
| Forendo Pharma | - | FUNDING ROUND - Forendo Pharma | 15.2M |
| Karolinska | - | FUNDING ROUND - Karolinska | 15.2M |
Recent Activity
There is no recent news or activity for this profile.